Cushing's syndrome
Overview
Causes of Cushing's syndrome
| Feature | Cushing's disease (pituitary adenoma) | Adrenal adenoma | Ectopic ACTH |
|---|---|---|---|
| ACTH level | High (normal or elevated) | Low / suppressed | Very high |
| High-dose DST: ACTH | Suppressed | Already suppressed | NOT suppressed |
| High-dose DST: cortisol | Suppressed | NOT suppressed | NOT suppressed |
| Hyperpigmentation | Mild | Absent | Prominent |
| Key association | Bitemporal hemianopia if macroadenoma | Autonomous adrenal cortisol secretion | Small cell lung cancer / pulmonary carcinoid |
Presentation
•Central obesity ('lemon on a stick') - fat redistribution to visceral/truncal depots with thin limbs
•Moon face and buffalo hump - fat redistribution to face and dorsocervical region
•Proximal myopathy - cortisol catabolises skeletal muscle; difficulty rising from chair / climbing stairs
•Purple striae (>1 cm, abdominal) - impaired collagen synthesis
•Easy bruising and thin skin
•Hypertension - mineralocorticoid activity, sodium and water retention
•Hirsutism, acne, amenorrhoea - excess ACTH drives adrenal androgen production (ACTH-dependent disease)
•Hyperpigmentation - high ACTH states only (ACTH shares homology with MSH); prominent in ectopic ACTH
•Impaired glucose tolerance / diabetes - cortisol promotes gluconeogenesis and insulin resistance
•Bitemporal hemianopia - pituitary macroadenoma compressing optic chiasm
Investigations
•Screening (confirm cortisol excess):
•Overnight 1 mg dexamethasone suppression test (DST) - 1 mg at 11 pm; cortisol at 9 am; normal suppression <50 nmol/L
•24-hour urinary free cortisol - integrates cortisol over full day, avoids moment-to-moment variability
•Late-night salivary cortisol - exploits loss of diurnal rhythm; cortisol remains elevated at midnight in disease
•Localisation (identify source): plasma ACTH level is the first step - low ACTH = ACTH-independent (adrenal); high/normal ACTH = ACTH-dependent (pituitary or ectopic)
•High-dose DST - distinguishes pituitary adenoma (both suppressed) from ectopic ACTH (neither suppressed) and adrenal adenoma (ACTH already low, cortisol not suppressed)
•CT adrenal glands - next investigation when ACTH-independent disease confirmed; non-invasive, identifies adrenal adenoma
Management
•Exogenous Cushing's syndrome: gradual reduction of glucocorticoid dose under specialist supervision - abrupt withdrawal risks adrenal crisis
•Cushing's disease (pituitary adenoma): transsphenoidal adenomectomy - first-line; cure rates ~70-90%
•Adrenal adenoma: laparoscopic adrenalectomy; post-operative adrenal insufficiency expected - contralateral gland suppressed, requires temporary glucocorticoid replacement
•Ectopic ACTH syndrome: treat underlying tumour; bridge with metyrapone or ketoconazole to control cortisol
🥈 Second-line
•pituitary radiotherapy for recurrent Cushing's disease; metyrapone or ketoconazole as bridging/medical therapy
🥉 Third-line
•bilateral adrenalectomy for refractory ACTH-dependent disease - causes permanent adrenal insufficiency and risks Nelson's syndrome (pituitary tumour enlargement due to loss of cortisol feedback, presenting with hyperpigmentation and visual field defects)